[Clinical Significance of Bidirectional Interactions between Obsessive-compulsive Disorder and Depressive Disorders].

Hisato Matsunaga
{"title":"[Clinical Significance of Bidirectional Interactions between Obsessive-compulsive Disorder and Depressive Disorders].","authors":"Hisato Matsunaga","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Major depressive disorder (MDD) has consistently been regarded as the most frequently diagnosed comorbid disorder in patients with obsessive-compulsive disorder (OCD). More than half of OCD patients have the lifetime comorbidity of MDD, which is more likely to develop after the onset of OCD. MDD may occur in response to the chronic distress and functional impairments associated with OCD, resulting in either a negative impact on the quality of life of these patients or poor responses to treatments and unfavorable prognoses. However, obses- sions, particularly aggressive obsessions, and excessive anxiety have been identified as contrib- uting factors to the occurrence of comorbid MDD, which may support the possible role of an altered relationship between the orbitofrontal cortex and amygdala/parahippocampal region in the development of lifetime MDD in OCD patients. Thus, based on the heterogeneity of OCD, the cognitive (typical) type of OCD, which is characterized by the presence of obsessions or cognitive processes resulting in provoked anxiety and compulsions, is more likely to develop comorbid MDD than the motoric type of OCD that accompanies compulsions to alleviate tension related to sensory phenomena such as feelings of incompleteness and urges to reach a specific sensation of feeling \"just right\". Even though comorbid MDD does not markedly impact on the phenomenological or psychopathological features of OCD, bidirectional interactions between these disorders need to be considered in order to establish adequate treatment strategies for such OCD patients. Pre- ceding pharmacotherapies such as SSRI are indispensable in these treatments because of the possible refractoriness associated with such a concurrently depressive condition to CBT. Fur- thermore, SSRI augmentations with antidepressants that enhance noradrenergic function may sometimes be effective in the treatment of OCD with comorbid MDD. The influences of environmental factors and/or personality pathology need to be evaluated in order to assess the addition of further treatment options such as environmental manipulations, family-focused interventions, cognitive therapies, or interpersonal psychotherapy, especially for OCD patients with treatment-refractory MDD.</p>","PeriodicalId":21638,"journal":{"name":"Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica","volume":"118 7","pages":"522-530"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Major depressive disorder (MDD) has consistently been regarded as the most frequently diagnosed comorbid disorder in patients with obsessive-compulsive disorder (OCD). More than half of OCD patients have the lifetime comorbidity of MDD, which is more likely to develop after the onset of OCD. MDD may occur in response to the chronic distress and functional impairments associated with OCD, resulting in either a negative impact on the quality of life of these patients or poor responses to treatments and unfavorable prognoses. However, obses- sions, particularly aggressive obsessions, and excessive anxiety have been identified as contrib- uting factors to the occurrence of comorbid MDD, which may support the possible role of an altered relationship between the orbitofrontal cortex and amygdala/parahippocampal region in the development of lifetime MDD in OCD patients. Thus, based on the heterogeneity of OCD, the cognitive (typical) type of OCD, which is characterized by the presence of obsessions or cognitive processes resulting in provoked anxiety and compulsions, is more likely to develop comorbid MDD than the motoric type of OCD that accompanies compulsions to alleviate tension related to sensory phenomena such as feelings of incompleteness and urges to reach a specific sensation of feeling "just right". Even though comorbid MDD does not markedly impact on the phenomenological or psychopathological features of OCD, bidirectional interactions between these disorders need to be considered in order to establish adequate treatment strategies for such OCD patients. Pre- ceding pharmacotherapies such as SSRI are indispensable in these treatments because of the possible refractoriness associated with such a concurrently depressive condition to CBT. Fur- thermore, SSRI augmentations with antidepressants that enhance noradrenergic function may sometimes be effective in the treatment of OCD with comorbid MDD. The influences of environmental factors and/or personality pathology need to be evaluated in order to assess the addition of further treatment options such as environmental manipulations, family-focused interventions, cognitive therapies, or interpersonal psychotherapy, especially for OCD patients with treatment-refractory MDD.

强迫症与抑郁症双向相互作用的临床意义
重度抑郁障碍(MDD)一直被认为是强迫症(OCD)患者中最常见的合并症。超过一半的强迫症患者终生伴有重度抑郁症,而重度抑郁症更有可能在强迫症发病后出现。重度抑郁症可能发生在与强迫症相关的慢性痛苦和功能障碍的反应中,导致这些患者的生活质量受到负面影响,或对治疗反应不佳和预后不利。然而,肥胖,特别是攻击性强迫症和过度焦虑已被确定为并发MDD的因素,这可能支持眶额皮质和杏仁核/海马旁区之间关系的改变在OCD患者终身MDD发展中的可能作用。因此,基于强迫症的异质性,认知型(典型)强迫症,其特征是存在强迫或认知过程,导致诱发焦虑和强迫,比运动型强迫症更有可能发展为共病性重度抑郁症,运动型强迫症伴随着强迫,以缓解与感觉现象相关的紧张,如不完整感和渴望达到“恰到好处”的特定感觉。尽管共病性重度抑郁症对强迫症的现象学或精神病理学特征没有显著影响,但为了建立适当的治疗策略,需要考虑这些疾病之间的双向相互作用。治疗前的药物治疗,如SSRI,在这些治疗中是必不可少的,因为这种并发抑郁状态与CBT可能存在难治性。此外,SSRI增强抗抑郁药增强去甲肾上腺素能功能有时可能对强迫症合并重度抑郁症的治疗有效。需要评估环境因素和/或人格病理的影响,以便评估进一步的治疗选择,如环境操纵,以家庭为中心的干预,认知疗法或人际心理治疗,特别是对治疗难治性重度抑郁症的强迫症患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信